Monday, January 27, 2020

Micro-scaled method holds promise as improved cancer diagnostic platform

A new-method analyzes the combination of tumor genetic material (genomics) with deep protein and phosphoprotein characterization (proteomics) using a single-needle core biopsy from a patient's tumor, providing more detailed information about the cancer than conventional approaches.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/01/200127134720.htm

No comments:

Post a Comment